open access

Vol 62, No 6 (2011)
Original papers
Published online: 2011-12-06
Submitted: 2013-02-15
Get Citation

Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to oestroprogestagen treatment

Elżbieta Sowińska-Przepiera, Elżbieta Andrysiak-Mamos, Justyna Syrenicz, Grażyna Jarząbek-Bielecka, Zbigniew Friebe, Anhelli Syrenicz
Endokrynologia Polska 2011;62(6):492-498.

open access

Vol 62, No 6 (2011)
Original papers
Published online: 2011-12-06
Submitted: 2013-02-15

Abstract

Background: We investigated whether the vitamin D3 receptor gene (VDR) polymorphism can modulate therapeutic response of functional hypothalamic amenorrhea (FHA) patients to the oestroprogestagen (EP) treatment.
Material and methods: The study included 84 FHA girls and 50 controls. FHA patients underwent a four-year sequential EP therapy with 17-β oestradiol (2 mg from the 2nd to 25th day of the menstrual cycle) and didrogesterone (10 mg from the 16th to the 25th day). Their hormonal parameters were monitored along with bone turnover marker levels and bone mineral density (BMD). Additionally, the VDR gene BsmI polymorphism was determined.
Results: Hormonal therapy was reflected by a substantial improvement of BMD. However, the values of BMD observed after four years of treatment in FHA patients were still significantly lower than baseline bone mineral density determined in the control group (1.007 &#177; 0.100 vs. 1.141 &#177; 0.093 g/cm2, respectively; p < 0.001). No significant effects of the VDR genotype were observed on the dynamics of BMD during consecutive years of hormonal treatment and mean bone mineral density determined after completing the therapy (1.006 &#177; 0.101 vs. 1.013 &#177; 0.114 vs. 1.006 &#177; 0.094 g/cm2 for BB, bb and Bb genotypes, respectively; p = 0.973).
Conclusions: This study did not confirm that VDR polymorphism can modulate therapeutic outcome of FHA girls subjected to the hormonal treatment. Nonetheless, this study confirmed the effectiveness of EP therapy in the simultaneous treatment of menstrual disorders and the normalisation of bone mineral density in FHA patients. (Pol J Endocrinol 2011; 62 (6): 492&#8211;498)

Abstract

Background: We investigated whether the vitamin D3 receptor gene (VDR) polymorphism can modulate therapeutic response of functional hypothalamic amenorrhea (FHA) patients to the oestroprogestagen (EP) treatment.
Material and methods: The study included 84 FHA girls and 50 controls. FHA patients underwent a four-year sequential EP therapy with 17-&#946; oestradiol (2 mg from the 2nd to 25th day of the menstrual cycle) and didrogesterone (10 mg from the 16th to the 25th day). Their hormonal parameters were monitored along with bone turnover marker levels and bone mineral density (BMD). Additionally, the VDR gene BsmI polymorphism was determined.
Results: Hormonal therapy was reflected by a substantial improvement of BMD. However, the values of BMD observed after four years of treatment in FHA patients were still significantly lower than baseline bone mineral density determined in the control group (1.007 &#177; 0.100 vs. 1.141 &#177; 0.093 g/cm2, respectively; p < 0.001). No significant effects of the VDR genotype were observed on the dynamics of BMD during consecutive years of hormonal treatment and mean bone mineral density determined after completing the therapy (1.006 &#177; 0.101 vs. 1.013 &#177; 0.114 vs. 1.006 &#177; 0.094 g/cm2 for BB, bb and Bb genotypes, respectively; p = 0.973).
Conclusions: This study did not confirm that VDR polymorphism can modulate therapeutic outcome of FHA girls subjected to the hormonal treatment. Nonetheless, this study confirmed the effectiveness of EP therapy in the simultaneous treatment of menstrual disorders and the normalisation of bone mineral density in FHA patients. (Pol J Endocrinol 2011; 62 (6): 492&#8211;498)
Get Citation

Keywords

bone mineral density; vitamin D3 receptor; functional hypothalamic amenorrhea; hormone replacement therapy; osteoporosis

About this article
Title

Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to oestroprogestagen treatment

Journal

Endokrynologia Polska

Issue

Vol 62, No 6 (2011)

Pages

492-498

Published online

2011-12-06

Bibliographic record

Endokrynologia Polska 2011;62(6):492-498.

Keywords

bone mineral density
vitamin D3 receptor
functional hypothalamic amenorrhea
hormone replacement therapy
osteoporosis

Authors

Elżbieta Sowińska-Przepiera
Elżbieta Andrysiak-Mamos
Justyna Syrenicz
Grażyna Jarząbek-Bielecka
Zbigniew Friebe
Anhelli Syrenicz

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl